O. Stella Latinovic, PhD MBA PMC
NIH PROGRAM OFFICER
Baltimore/DC 610-***-**** **************@*****.*** linkedin.com/in/latinovic-o-s-msc-phd-mba-ba86966/ Professional Summary
Throughout my 15-year career in innovative biotechnology/clinical programs (anti-HIV therapies and pharmacology), I have ensured that academic proposals, contracts, and federal grants comply with federal and institutional policies. I managed a $25 million federal grants portfolio in a program officer role at NIH/NIAID, where I provided scientific and administrative guidance for biomedical trials, while developing and implementing activities related to promoting federal regulations. This includes guiding grantees in the operational aspects of federal grants, policy development, compliance, implementation, budget management, and preparing program summary reports. As a Principal Investigator (PI) at the University of Maryland School of Medicine (UMSOM), I spearheaded innovative biotechnology research programs, accompanied by strong collaboration with numerous corporate stakeholders. With expertise in strategic planning of biotechnology programs, clinical program development, cross- functional scientific project management, and supervising, I excelled at leading multi-disciplinary biomedical-oriented teams and results-driven clinical research programs. Fostering interdisciplinary research was imperative for me as a PI, resulting in 45+ peer-reviewed publications.
I leverage strategic thinking and data analytics expertise to develop operational assessments that propel biotechnology programs forward. Proficient in budget management, contract/ grant writing/management, and proactive coalition development, I empower teams to achieve outstanding results. Fostering a culture of innovation, diversity, progressive thinking, and collaborative leadership, I champion the achievement of excellence. I pride myself on honoring differences in opinions to get projects accomplished. My ultimate career goal is to harness this unique skill set to be an integral part of your organization, while promoting its standards. My imperative is to contribute and commit to your institution’s excellence and mission.
Core Competencies
• Project/ Program management skills in leading multidisciplinary/multiphase projects
• Problem-solving skills anchored with multi-tasking skills / effective time management
• Proficiency in federal policy, regulations management, and process implementation improvements
• Operational efficiency in a dynamic organization’s environment while providing alternative project strategies
• Extraordinary communication skills; Presenting information clearly in verbal / written forms Professional Experience
Program Official/ Health Science Administrator GS-14 NIH/NIAID Rockville, MD (2024- 2025)
• Developing, implementing federal regulations, tracking policy developments, and program content preparation
• Provided administrative supervision for applicants/ awardees while offering expedited economic plans
• Oversaw all RFAs, FARs documentation of institutional workflow completion and records
• Managed grants portfolio balanced by protocol regulations and biomedical standards implementation
• Recommended instructional NIH policies and collegial decision-making culture Accomplishments:
• Identification of critical scientific gaps/ strategies that accelerated drug development /clinical pharmacology
• Leadership Committee member: NIH Critical Transformative Science Group / 5 NIH clinical trials Senior Scientific Program Manager, Kelly Government Solutions (NIH/NIAID), Rockville, MD (2021-2024)
• Managed innovative clinical trials (multi-antibody/cART-based) that advanced HIV treatment
• Ensured compliance with accreditation and regulatory requirements of NIH and FDA’s policies and procedures
• Oversaw organizational, risk, and financial management of a $20M budget with high-quality service delivery
• Recommended planning of new projects, providing biomedical expert advice
• Guided administrative documentation for Scientific advisory board meetings, Councils, and progress reports
• Represented NIH in meetings with government officials, at professional international/national conferences Accomplishments:
• NIH/NIAID Recognition Administrative Award in December 2023 2
• Successful identification of the cost-effective, next-generation reagents for HIV/AIDS treatment
• Collaborated in a centralized database for integrated antiviral pharma products (Decision Lens, VA) Senior Consultant, Global Virus Network, Corporate Partnership Programs, Baltimore, MD (2019-2021)
• Directed the administrative expansion of the Coalition’s capabilities and contracts for collaborative offerings
• Wrote and reviewed technical protocols, contracts and analytical reports for training programs
• Led collaborative efforts on partnership programs with Pfizer, Sanofi, Thermo Fisher, and Merck Accomplishments:
• Secured three funding opportunities and five postdoctoral fellowships
• Facilitated academic partnerships and contracts between program faculty and GVN Coalition Head, Lab for the Pathogen & Cell Interaction Institute of Human Virology, UMSOM (2011-2021)
• Wrote all first/last author manuscripts for publication in scientific journals and technical contracts/ manuals/ reports
• Lead PI in multiple in vivo antiretroviral programs (hu-mouse models)
• Wrote and managed federal grant proposals, annual reports for SAB/BOA
• Led multidisciplinary and multi-phase biomedical research programs (trained/ supervised 29 staff members)
• Coordinated quality assurance programs for laboratories performing HIV-1 testing with cost reduction
• Participated in the PEPFAR program in 11 African and Caribbean countries, treating 750,000 people
• Authored and presented scientific seminars in multiple international and national virology conferences Accomplishments:
• The first published investigator to use synergistic combo treatments in vivo (antibodies/fusion proteins FLSC IgG1)
• Developed/ First published novel Beta Lactamase Virus Entry Assay in primary cells (PNAS, 2012)
• Executed implementation protocols resulting in advancements in treatment strategies Director, Bioimaging Training Facility, Institute of Human Virology, UMSOM (2012-2021)
• Established first IHV bioimaging core, managed 5 sole-source deliverables, and developed biomedical programs
• Managed budgets and contracts in the newly established centralized facility / Authored its mission statement
• Execution of bioimaging projects for HIV vaccine clinical trials (funded by the Bill and Melinda Gates Foundation)
• Customer-focused bioimaging service
• Developed novel methods for data acquisition and analysis (resulting in awarded PO1s, RO1s, R21s)
• Ensured the enterprise of the Institution's business development/ revenue collection with trade-off saving $100K Accomplishments:
• Built the First Imaging Facility with a state-of-the-art super-resolution microscope / managed self-funded facility
• Executed two collaborative programs with Pfizer Inc (NYC, NY) and Profectus Biosciences (Baltimore, MD)
• Cover page microscopy image for the Journal of Leukocyte Biology (2016). pii: jlb.2A1114-534R Education
Project Management Certificate, University of Maryland (2021) MBA (Healthcare management), University of Baltimore (2020) PhD, Lehigh University (2006)
Select publications: https://pubmed.ncbi.nlm.nih.gov/?term=olga+latinovi Honors and Certificates
• Data Analytics Professional Certificate (SQL and R) (2025)
• Johns Hopkins Carey Business School Executive Education Certificate (2024)
• NIH Human Subjects Protection (2023)
• NIH Integrated Core Curriculum Course for Program Officers (2022)
• NIH Clinical Pharmacology Course Certificate (2022)
• NIH Office of Clinical Research Certificate (2021)
• Organizing Committee Member, Virology Congress Webinar (2021)
• Adjunct Faculty at Microbiology and Immunology Dept, UMSOM (2021)
• Organizing Committee Member, International Conference & Immunology, Brussels, Belgium (2020)
• Scientific Director, Healthcare League Conference, Lisbon, Portugal (2020)
• Editor-in-Chief for the Journal of AIDS and HIV Treatment (2019)
• Executive Editor for Current Research in Virology and Retrovirology (2017)